Informations générales (source: ClinicalTrials.gov)

NCT03823963 Statut inconnu
A Monocentric, Comparative and Randomized Study on Pressure Ulcers Prevention With Mepilex® Border Sacrum Dressing in Scheduled Cardiovascular Surgery (MEPICARD)
Interventional
  • Escarre
  • Ulcère cutané
  • Ulcère
Phase 4
University Hospital, Clermont-Ferrand (Voir sur ClinicalTrials)
décembre 2018
janvier 2020
29 juin 2024
The study is a randomised controlled trial of patients admitted for a scheduled cardiac surgery at the Clermont-Ferrand hospital. Patients meeting the study inclusion criteria will be allocated to either the control group that will receive pressure ulcer prevention standard care or the intervention group that will receive pressure ulcer prevention standard care plus have a Mepilex® Border dressing applied to their sacrum.
 Voir le détail

Etablissements

Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
Chu Clermont-Ferrand - 63003 - Clermont-Ferrand - France Lise LACLAUTRE En recrutement Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- Subject over 18 years of age,

- Subject programmed to benefit from cardiac surgery with sternotomy,

- Subject capable and willing to comply with the protocol and willing to give his
written consent,

- Subject affiliated to a social security system


- Subject with a skin lesion in the sacral area upon admission,

- Subject admitted for emergency cardiovascular surgery (unscheduled subject),

- Subject admitted for heart transplant surgery,

- Subject participating in another clinical study or in a period of exclusion from a
study previous,

- Subject with a linguistic or psychological disability to sign informed consent,

- Subject refusing to give written consent,

- Subject deprived of liberty by administrative or judicial decision, under
guardianship or curatorship.